PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,074,000 | +82.0% | 1,293,289 | +68.2% | 0.01% | +50.0% |
| Q2 2020 | $2,238,000 | +4661.7% | 769,081 | +4533.0% | 0.00% | – |
| Q1 2020 | $47,000 | -92.5% | 16,600 | -91.4% | 0.00% | -100.0% |
| Q4 2019 | $630,000 | -26.9% | 194,000 | -51.4% | 0.00% | -50.0% |
| Q3 2019 | $862,000 | -85.0% | 398,950 | -78.1% | 0.00% | -84.6% |
| Q2 2019 | $5,732,000 | -40.1% | 1,825,381 | -29.1% | 0.01% | -43.5% |
| Q1 2019 | $9,576,000 | +2716.5% | 2,574,283 | +2098.3% | 0.02% | +2200.0% |
| Q4 2018 | $340,000 | +14.1% | 117,105 | -10.7% | 0.00% | 0.0% |
| Q1 2017 | $298,000 | – | 131,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |